Literature DB >> 14656978

Integrated evolutionary, immunological, and neuroendocrine framework for the pathogenesis of chronic disabling inflammatory diseases.

Rainer H Straub1, Hugo O Besedovsky.   

Abstract

The pathogenesis of chronic disabling inflammatory diseases (CDIDs) is poorly understood. Current concepts that focus on abnormalities of the immune system are, in our view, incomplete. Here we propose that chronic disruption of homeostasis through abnormal neuronal and endocrine host responses to transient inflammatory reactions contributes to the appearance of CDIDs. Coordinated reactions of the supersystems (immune, nervous, endocrine, and reproductive) that maintain homeostasis have been evolutionarily conserved to respond to and eliminate foreign agents over a period of days to a few weeks. If the responses of these supersystems fail to return to normal after elimination of the pathogen, a continuous aggressive immune response is created; this situation can trigger development of CDIDs. Maladaptation of the supersystems during CDIDs has not been evolutionarily conserved but is nevertheless still prevalent because a large proportion of these diseases tend to appear after the reproductive phase. We propose that this integrated systems hypothesis may permit better identification of a patient at risk or in the early stages of developing a CDID such as rheumatoid arthritis and enable more coordinated intervention than is presently attempted.

Entities:  

Mesh:

Year:  2003        PMID: 14656978     DOI: 10.1096/fj.03-0433hyp

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  23 in total

1.  [Neuroendocrine immunology: new pathogenetic aspects and clinical application].

Authors:  R H Straub
Journal:  Z Rheumatol       Date:  2011-11       Impact factor: 1.372

2.  IL-1 resets glucose homeostasis at central levels.

Authors:  Adriana Del Rey; Eduardo Roggero; Anke Randolf; Carolina Mahuad; Samuel McCann; Valeria Rettori; Hugo O Besedovsky
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-11       Impact factor: 11.205

Review 3.  [Why are there analogous disease mechanisms in chronic inflammatory diseases?].

Authors:  Rainer H Straub; Hugo O Besedovsky; Adriana Del Rey
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

Review 4.  Evolutionary medicine and bone loss in chronic inflammatory diseases--A theory of inflammation-related osteopenia.

Authors:  Rainer H Straub; Maurizio Cutolo; Roberto Pacifici
Journal:  Semin Arthritis Rheum       Date:  2015-04-30       Impact factor: 5.532

Review 5.  The systemic nature of CKD.

Authors:  Carmine Zoccali; Raymond Vanholder; Ziad A Massy; Alberto Ortiz; Pantelis Sarafidis; Friedo W Dekker; Danilo Fliser; Denis Fouque; Gunnar H Heine; Kitty J Jager; Mehmet Kanbay; Francesca Mallamaci; Gianfranco Parati; Patrick Rossignol; Andrzej Wiecek; Gerard London
Journal:  Nat Rev Nephrol       Date:  2017-04-24       Impact factor: 28.314

Review 6.  The role of the sympathetic nervous system in intestinal inflammation.

Authors:  R H Straub; R Wiest; U G Strauch; P Härle; J Schölmerich
Journal:  Gut       Date:  2006-11       Impact factor: 23.059

7.  Prenatal alcohol exposure alters the course and severity of adjuvant-induced arthritis in female rats.

Authors:  Xingqi Zhang; Ni Lan; Paxton Bach; David Nordstokke; Wayne Yu; Linda Ellis; Gary G Meadows; Joanne Weinberg
Journal:  Brain Behav Immun       Date:  2011-12-01       Impact factor: 7.217

Review 8.  [Neuroendocrine immune interactions in rheumatic diseases].

Authors:  R H Straub; A Fassold
Journal:  Z Rheumatol       Date:  2010-06       Impact factor: 1.372

9.  Quantitative Systems Pharmacology: A Framework for Context.

Authors:  Ioannis P Androulakis
Journal:  Curr Pharmacol Rep       Date:  2016-04-08

Review 10.  TRPV1, TRPA1, and TRPM8 channels in inflammation, energy redirection, and water retention: role in chronic inflammatory diseases with an evolutionary perspective.

Authors:  Rainer H Straub
Journal:  J Mol Med (Berl)       Date:  2014-05-29       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.